FDA reviews new painkiller

Share this article:

The FDA is set to review another drug that could join the prescription painkiller mix today. NPR reports that the latest pain reliever combines morphine and oxycodone. The all-in-one medication called Moxduo would be the first to combine the two pain relievers.

COO of drugmaker QRXPharma Ed Rudnic tells NPR that patients end up taking less of each drug with this medication than they would if prescribed both separately.

Painkillers have become a hot topic among lawmakers and addiction specialists because of a rise in opioid abuse. Massachusetts recently tried to ban opioid Zohydro in an effort to curb opioid abuse, but a court found the ban was unconstitutional.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.